Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023

医学 疾病负担 疾病 疾病负担 环境卫生 公共卫生 人口 死因 全球卫生 发达国家 人口健康 风险因素 双重负担 风险评估 医疗保健系统 流行病学 肥胖 梅德林 世界人口 心血管健康 发展中国家
作者
Benjamin A. Stark,Nicole K. DeCleene,Emily C. Desai,Johnathan M. Hsu,Catherine O. Johnson,Laura Lara-Castor,Kate E. LeGrand,Prof Bhoomadevi A,Mohammad Amin Aalipour,Hasan Aalruz,Bedru J. Abafita,Ukachukwu O. Abaraogu,Mohammad Abavisani,Nasir Abbas,Madineh Abbasi,Mohammadreza Abbasian,Hedayat Abbastabar,Abdallah H.A. Abd Al Magied,Samar Abd ElHafeez,Prof Ahmed Abdelalim
出处
期刊:Journal of the American College of Cardiology [Elsevier BV]
卷期号:86 (22): 2167-2243 被引量:1099
标识
DOI:10.1016/j.jacc.2025.08.015
摘要

BACKGROUND: Cardiovascular diseases (CVDs) are the leading cause of mortality and are among the foremost causes of disability globally. CVD burden has continued to increase in most countries since 1990, with trends driven by changing exposures to harmful risk factors, population growth, and population aging. OBJECTIVES: We report estimates of global, national, and subnational CVD burden, including 18 subdiseases and 12 associated modifiable risk factors. We analyzed change in CVD burden from 1990 to 2023 and identified drivers of change including population growth, population aging, and risk factor exposure. METHODS: The Global Burden of Disease (GBD) 2023 study, a multinational collaborative research study, quantified burden due to 375 diseases including CVD burden and identified drivers of change from 1990 to 2023 using all available data and statistical models. GBD 2023 estimated the population-level burden of diseases in 204 countries and territories from 1990 to 2023. RESULTS: CVDs were the leading cause of disability-adjusted life years (DALYs) and deaths estimated in the GBD. As of 2023, there were 437 million (95% UI: 401 to 465 million) CVD DALYs globally, a 1.4-fold increase from the number in 1990 of 320 million (292 to 344 million). Ischemic heart disease, intracerebral hemorrhage, ischemic stroke, and hypertensive heart disease were the leading cardiovascular causes of DALYs in 2023 globally. As of 2023, age-standardized CVD DALY rates were highest in low and low-middle Socio-demographic Index (SDI) settings and lowest in high SDI settings. The number of CVD deaths increased globally from 13.1 million (95% UI: 12.2 to 14.0 million) in 1990 to 19.2 million (95% UI: 17.4 to 20.4 million) in 2023. The number of prevalent cases of CVD more than doubled since 1990, with 311 million (95% UI: 294 to 333 million) prevalent cases of CVD in 1990 and 626 million (95% UI: 591 to 672 million) prevalent cases in 2023 globally. A total of 79.6% (95% UI: 75.7% to 82.5%) of CVD burden is attributable to modifiable risk factors 347 million [95% UI: 318 to 373 million] DALYs in 2023). Globally, high systolic blood pressure, dietary risks, high low-density lipoprotein cholesterol, and air pollution were the modifiable risks responsible for most attributable CVD burden in 2023. Since 1990, changes in exposure to modifiable risk factors have had mixed effects on CVD burden, with increases in high body mass index, high fasting plasma glucose, and low physical activity leading to higher burden, while reductions in tobacco usage have mitigated some of these increases. Population growth and population aging were the main drivers of the increasing burden since 1990, adding 128 million (95% UI: 115 to 139 million) and 139 million (95% UI: 126 to 151 million) CVD DALYs to the increase in CVD burden since 1990. CONCLUSIONS: CVD remains the leading cause of disease burden and death worldwide with the greatest burden in low, low-middle, and middle SDI regions. Large variation exists in CVD burden even for countries at similar levels of development, a gap explained substantially by known, modifiable risk factors that are inadequately controlled. The decades-long increase in CVD burden was the result of population growth, population aging, and increased exposure to a subset of risk factors led by metabolic risks. Countries will need to adopt effective health system and public health strategies if they are to progress in achieving global goals to reduce the burden of CVD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
假真真完成签到 ,获得积分10
刚刚
清淮完成签到 ,获得积分10
刚刚
夏安完成签到,获得积分10
刚刚
柿子完成签到,获得积分10
2秒前
悦耳的保温杯完成签到 ,获得积分10
5秒前
淮安石河子完成签到 ,获得积分10
6秒前
6秒前
水water完成签到 ,获得积分10
7秒前
7秒前
waveless完成签到,获得积分10
8秒前
yy完成签到,获得积分10
9秒前
zhangnan完成签到 ,获得积分10
9秒前
Sweet完成签到 ,获得积分10
11秒前
愛愛愛愛完成签到,获得积分10
11秒前
tanjuan发布了新的文献求助10
13秒前
彳亍宣完成签到 ,获得积分10
15秒前
嗡嗡声完成签到 ,获得积分10
18秒前
19秒前
茄子回锅肉完成签到,获得积分10
20秒前
姚怜南完成签到,获得积分10
21秒前
忧心的藏鸟完成签到 ,获得积分10
21秒前
飞飞完成签到,获得积分10
23秒前
沐野完成签到 ,获得积分10
23秒前
科研通AI2S的应助被季末默相依采纳,获得10
25秒前
25秒前
qiuy发布了新的文献求助10
25秒前
Arctic完成签到 ,获得积分10
25秒前
Justtry完成签到,获得积分10
27秒前
英姑的应助被thchiang采纳,获得10
27秒前
28秒前
苗条的访冬完成签到 ,获得积分10
30秒前
dyy完成签到 ,获得积分10
33秒前
Heaven完成签到 ,获得积分10
33秒前
秋风的应助被qiuy采纳,获得20
34秒前
踏实的凝冬完成签到 ,获得积分10
36秒前
Prometheusss发布了新的文献求助10
37秒前
兴奋的惮完成签到,获得积分10
37秒前
999完成签到 ,获得积分10
38秒前
3kyo完成签到 ,获得积分10
41秒前
文静的惜霜完成签到,获得积分10
42秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180084
求助须知:如何正确求助?哪些是违规求助? 9570224
关于积分的说明 21808758
捐赠科研通 7776098
什么是DOI,文献DOI怎么找? 3433261
关于科研通互助平台的介绍 2557454
邀请新用户注册赠送积分活动 2479012